Stay updated on Adagrasib + BI 1701963 in Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + BI 1701963 in Cancer Clinical Trial page.

Latest updates to the Adagrasib + BI 1701963 in Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.4.2 has been added to the Study Record Versions, and the funding-lapse notice along with the v3.4.1 revision entry have been removed.SummaryDifference0.8%

- Check35 days agoChange DetectedA site-wide notice about government funding and a new site version (v3.4.1) were added, while the previous version tag (v3.4.0) was removed. These updates do not affect the study record details or history.SummaryDifference0.8%

- Check42 days agoChange DetectedAdded a glossary toggle and color-diff explanations, and updated revision labels from v3.3.4 to v3.4.0 on the history page.SummaryDifference1%

- Check56 days agoChange DetectedA new revision v3.3.4 was added to the record history, and the previous v3.3.3 entry was removed. This update reflects an administrative change to the page’s version history rather than substantive changes to the study information.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision history now lists Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check106 days agoChange DetectedThe Record History now includes a new Revision entry for v3.3.2 and removes the v3.2.0 entry, representing a small release-level update to the history log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Adagrasib + BI 1701963 in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + BI 1701963 in Cancer Clinical Trial page.